An antidote for the billion dollar drug problem | Ep43

<p>Connect with Bonne Adams <a href='https://www.linkedin.com/in/bonne-adams-mba-58862417/'>https://www.linkedin.com/in/bonne-adams-mba-58862417/ </a></p> <p>Get the book <a href='https://www.amazon.com/Unnecessary-Expense-Antidote-Billion-Problem/dp/1950863573/ref=sr_1_1?crid=2MET3FIPAMUD5&keywords=unnecessary+expense+Charles+theuer&qid=1669744388&sprefix=unnecessary+expense+charles+theuer%2Caps%2C177&sr=8-1'>https://www.amazon.com/Unnecessary-Expense-Antidote-Billion-Problem/dp/1950863573/ref=sr_1_1?crid=2MET3FIPAMUD5&keywords=unnecessary+expense+Charles+theuer&qid=1669744388&sprefix=unnecessary+expense+charles+theuer%2Caps%2C177&sr=8-1 </a></p> <p> </p> <p>The drug development process in the United States is an expensive one. It costs an average of £2 billion to secure FDA approval for every new drug. So, what can we do to reduce these costs? Bonne Adams shares how Tracon Pharma https://www.traconpharma.com/ are tackling this head-on.</p>